Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

Healthcare Biotechnology

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > MDMA: Short Target

<< Previous

Bullboard Posts

Next >>

Comment by AjarnEvanon Apr 20, 2023 1:33am

57 Views

Post# 35404568

RE:MDMA: Short Target

Shorting this is a terrible idea. It's unbelievable that anyone would be so blind to what's happening in the industry and how MDMA.CN has capitalized. Talk cash and revenue when the big deals are finalized and that's right around the corner. Good luck!

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks